Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,071.2
6.7 (0.22%)

 

  • STI Straits Times Index
    3,071.2
    6.7 (0.22%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,548.5
    -6.8 (-0.43%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,920.8
    252.9 (1.03%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,614.0
    6.9 (0.19%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    30,500.0
    176.7 (0.58%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,133.2
    23.3 (0.38%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,452.5M
  • Value: 2,581.7M
  • Rise: 161
  • Fall: 177
  • Unch: 416

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.073+0.013
ESR-REIT0.475-0.010
OUE Com Reit0.445-
Sembcorp Marine0.084+0.001
StarhillGbl Reit0.630-0.005
ARA LOGOS Log Tr0.935+0.010
GSS Energy0.077+0.005
Lippo Malls Tr0.054+0.003
Singtel2.430+0.030
CapLand IntCom T2.000-0.020

World Indices

World Indices
Name Last Change
Nasdaq 15,044.0 -138.0
HSI 24,920.8 +252.9
HSCEI 8,940.5 +134.7
Jakarta 6,133.2 +23.3
Nikkei 225 30,500.0 +176.7
SSE Comp 3,614.0 +6.9
Shanghai A 3,787.7 +7.3
Shanghai B 273.1 -1.8
KOSPI 3,140.5 +10.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

FISHER & PAYKEL HEALTHCARE CORP FISHER & PAYKEL HEALTHCARE CORPORATION
Updated on 17 Sep 2021 (End of trading day)
Last (AUD): 31.500 Change: +0.960 High: 31.590 Remarks: -
Change (%): +3.14 Low: 30.790
Open 30.800 Yesterday's Close 30.54
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 758,434 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a 0.84869 Trailing EPS (AUD) e 0.84869 NAV (AUD) b 2.4247
PE a 37.116 Trailing PE f 37.116 Price / NAV b 12.9913
Dividend (AUD) d 0.417106 Cash In Hand (AUD) g 0.1551 Issued & Paid-up Shares c 576,759,280
Dividend Yield (%) d 1.324 Price / Cash In Hand g 203.095 Treasury Shares h 137,720
Beta - 75 Daysi 0.816 R-Squared - 75 Days(%)i 13.79 Market Cap (M) 18,167.917
Beta - 500 Daysi 0.932 R-Squared - 500 Days (%)i 16.54 Enterprise Value (M) 17,929.578
Piotroski F Score 6 Exchange Code FPH Par Value ( NZD ) n.a.
52 Weeks Volatility (%) 31.96 Free Float (%) 99.8
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 17 Sep 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 28 May 2021.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference FISHER & PAYKEL HEALTHCARE CORP ASX 18,167.917 37.116 37.116 12.9913 1.324
Industry Medical Specialties ASX 2,382.337 70.204 70.302 10.4280 0.781
Local Peer COCHLEAR LTD ASX 15,672.629 48.002 48.002 9.2100 1.070
Local Peer EBOS GROUP ASX 5,769.109 31.134 31.134 4.0886 2.447
Local Peer NANOSONICS LIMITED ASX 1,891.164 220.464 220.467 13.9488 -
Local Peer METRICS INCOME OPPORTUNITIES TRUST ASX 603.132 - - -422.4490 -
Local Peer INCANNEX HEALTHCARE LTD ASX 443.176 - - 51.9481 -
Local Peer AROA BIOSURGERY LTD ASX 365.793 - - 6.8023 -
Local Peer CLARITY PHARMACEUTICALS LTD ASX 348.341 - - 17.1717 -
Local Peer MEDICAL DEVELOPMENT INTL ASX 296.558 - - 4.3419 -
Local Peer VOLPARA HEALTH TECHNOLOGIES LTD ASX 314.191 - - 4.6940 -
Local Peer EMVISION MEDICAL DEVICES LTD ASX 213.588 - - 21.2473 -
Local Peer ATOMO DIAGNOSTICS LIMITED ASX 199.009 - - 6.6163 -
Local Peer SOMNOMED LIMITED ASX 177.932 - - 5.2917 -
Other Local Peers CYCLOPHARM LIMITED (ASX), IMPEDIMED LIMITED (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), OPTISCAN IMAGING (ASX), MICRO-X LTD (ASX), SDI LTD (ASX), CLEANSPACE HOLDINGS LTD (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), COMPUMEDICS (ASX), DIMERIX LTD (ASX), CARDIEX LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), RESPIRI LTD (ASX), RESONANCE HEALTH LTD (ASX), LBT INNOVATIONS LTD (ASX), ADHERIUM LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), OVENTUS MEDICAL LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), OSPREY MEDICAL INC NPV DFD 23/09/21(EX-SPLIT) (ASX), METALICITY LIMITED (ASX), USCOM LTD (ASX), TRUSCREEN GROUP LTD (ASX), ANALYTICA (ASX)
Global Peer DANAHER CORP NYSE 231,681.967 66.006 66.006 5.8671 0.221
Global Peer ABBOTT LABORATORIES NYSE 224,775.848 50.252 35.420 6.6502 1.206
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 234,792.459 36.830 27.314 6.3709 0.149
Global Peer MEDTRONIC PLC NYSE 174,551.557 48.406 44.953 3.3903 1.865
Global Peer INTUITIVE SURGICAL INC NASDAQ 123,425.795 116.374 76.067 11.3888 -
Global Peer STRYKER CORP NYSE 102,958.521 64.389 49.428 7.4500 0.860
Global Peer BECTON DICKINSON & CO NYSE 75,229.420 98.083 40.337 3.1173 1.234
Global Peer EDWARDS LIFESCIENCES CORP NYSE 74,437.830 90.403 50.901 14.5010 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 63,176.224 - 134.992 3.9629 -
Global Peer ALIGN TECHNOLOGY INC NASDAQ 56,839.293 32.006 81.379 16.7944 -
Other Global Peers IDEXX LABORATORIES INC (NASDAQ), DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), ALCON AG (NYSE), RESMED INC (NYSE), BAXTER INTERNATIONAL INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WATERS CORP (NYSE), BIO RAD LABORATORIES INC (NYSE), COOPER COS INC (NYSE), STERIS PLC (NYSE), PERKINELMER INC (NYSE), INSULET CORPORATION (NASDAQ), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), ABIOMED INC (NASDAQ), MASIMO CORPORATION (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), NOVOCURE LTD (NASDAQ), BRUKER CORPORATION (NASDAQ), QIAGEN NV (NYSE), MICROPORT (HKEx), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), WEIGAO GROUP (HKEx), TANDEM DIABETES CARE INC (NASDAQ), ANGELALIGN (HKEx), SOTERA HEALTH CO (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), STAAR SURGICAL CO (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), Top Glove (SGX), TOPGLOV (Bursa), QUIDEL CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), INMODE LTD (NASDAQ), HARTA (Bursa), ICU MEDICAL INC (NASDAQ), NEOGEN CORP (NASDAQ), LIVANOVA PLC (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), NEVRO CORP (NYSE), MERIT MEDICAL SYSTEMS (NASDAQ), INARI MEDICAL INC (NASDAQ), CONMED CORP (NYSE), CYTEK BIOSCIENCES INC (NASDAQ), CAREDX INC (NASDAQ), HAEMONETICS CORP (NYSE), ATRICURE INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), HESKA CORP (NASDAQ), OUTSET MEDICAL INC (NASDAQ), VENUS MEDTECH-B (HKEx), CELLDEX THERAPEUTICS INC (NASDAQ), GLAUKOS CORPORATION (NYSE), VERICEL CORP (NASDAQ), LIFETECH SCI (HKEx), BUTTERFLY NETWORK INC (NYSE), CARDIOFLOW-B (HKEx), SILK ROAD MEDICAL INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), PEIJIA-B (HKEx), IRHYTHM TECHNOLOGIES INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), ZYLOXTB-B (HKEx), KANGJI MEDICAL (HKEx), SUPERMX (Bursa), INOVIO PHARMACEUTICALS INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), AVANOS MEDICAL INC (NYSE), AK MEDICAL (HKEx), PROCEPT BIOROBOTICS CORP (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), PULMONX CORPORATION (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), SIGHT SCIENCES INC (NASDAQ), ATRION CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), NANO-X IMAGING LTD (NASDAQ), INOGEN INC (NASDAQ), VIEWRAY INC (NASDAQ), CERUS CORP (NASDAQ), ANGIODYNAMICS INC (NASDAQ), DERMTECH INC (NASDAQ), 908 DEVICES INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), CRYOLIFE INC (NYSE), MODERN DENTAL (HKEx), CIRC (HKEx), TRANSMEDICS GROUP INC (NASDAQ), CUTERA INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), EARGO INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SISRAM MED (HKEx), BIOVENTUS INC (NASDAQ), SURMODICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SI BONE INC (NASDAQ), INTERCURE LTD (NASDAQ), CHUNLI MEDICAL (HKEx), NYXOAH SA (NASDAQ), VAPOTHERM INC (NYSE), KDL MEDICAL (HKEx), AXOGEN INC (NASDAQ), PAVMED INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), ANTARES PHARMA INC (NASDAQ), ACOTEC-B (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), HEARTCARE-B (HKEx), FLUIDIGM CORP DEL (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), AVITA MEDICAL INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SOLITON INC (NASDAQ), BASECARE-B (HKEx), MISONIX INC (NASDAQ), IRADIMED CORP (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), NEUROPACE INC (NASDAQ), ZYNEX INC (NASDAQ), STEREOTAXIS INC (NYSE American), CLEARPOINT NEURO INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), ACUTUS MEDICAL INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), SIENTRA INC (NASDAQ), ONCOCYTE CORP (NASDAQ), CONFORMIS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), CVRX INC (NASDAQ), YESTAR HEALTH (HKEx), ACCURAY INCORPORATED (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), LUCIRA HEALTH INC (NASDAQ), PROFOUND MED CORP (NASDAQ), QUOTIENT LTD (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), PW MEDTECH (HKEx), DARIOHEALTH CORP (NASDAQ), INVACARE CORP (NYSE), SURGALIGN HOLDINGS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), INTRICOM CORP (NASDAQ), UGHealthcare (SGX), TELA BIO INC (NASDAQ), Medtecs Intl (SGX), TITAN MEDICAL INC (NASDAQ), CORMEDIX INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), NEURONETICS INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), VENUS CONCEPT INC (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), FONAR CORP (NASDAQ), ALPHA PRO TECH (NYSE American), IRIDEX CORP (NASDAQ), ELECTROMED INC (NYSE American), KELFRED (HKEx), CRYO-CELL INTERNATIONAL INC (NASDAQ), BIOLASE INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CHECK-CAP LTD (NASDAQ), NEPHROS INC (NASDAQ), CELSION CORPORATION (NASDAQ), LENSAR INC (NASDAQ), VINCENT MED (HKEx), VOLITIONRX LIMITED (NYSE American), ZOSANO PHARMA CORP (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), AVINGER INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), IMMUCELL CORP (NASDAQ), ELECTROCORE INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), RGTBHD (Bursa), PREDICTIVE ONCOLOGY INC (NASDAQ), APPLIED UV INC (NASDAQ), NEUROMETRIX INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), SENSUS HEALTHCARE INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), YUNNAN ENERGY (HKEx), BIOMERICA INC (NASDAQ), NEOVASC INC (NASDAQ), ADVENTA (Bursa), NANOVIBRONIX INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), DAXOR CORP (NYSE American), LKL (Bursa), INSPIREMD INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), Yunnan Energy (SGX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), Biolidics (SGX), VIVEVE MEDICAL INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), DYNATRONICS CORP (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE American), XTANT MEDICAL HLDGS INC (NYSE American), CYANOTECH CORP (NASDAQ), LIFE HEALTHCARE (HKEx), NUWELLIS INC (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ), Annica (SGX), HUAKANG BIOMED (HKEx), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.120
-0.38 %
10 Days --0.640
-1.99 %
20 Days --0.730
-2.26 %
Medium Term Return 3 Months -+2.830
+9.87 %
6 Months -+3.110
+10.95 %
1 Year 3.228+1.850
+17.13 %
Long Term Return 2 Years 3.228+15.810
+121.34 %
3 Years 3.228+17.640
+150.56 %
5 Years 3.363+22.110
+271.28 %
Annualised Return Annualised --
+30.00 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 25.250 - 34.770 Change From 1 Year Low +6.250 % Change From 1 Year Low (%) +24.75
Change From 1 Year High -3.270 % Change From 1 Year High (%) -9.40
2 Years Range 15.580 - 34.920 Change From 2 Years Low +15.920 % Change From 2 Years Low (%) +102.18
Change From 2 Years High -3.420 % Change From 2 Years High (%) -9.79
5 Years Range 7.700 - 34.920 Change From 5 Years Low +23.800 % Change From 5 Years Low (%) +309.09
Change From 5 Years High -3.420 % Change From 5 Years High (%) -9.79
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Fisher & Paykel Healthcare Corp. Ltd. engages in the designing, manufacturing and marketing of medical device products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. It operates through the following geographical segments: The New Zealand, North America, Europe, and Asia-Pacific. The New Zealand segment includes all activities controlled by entities or employees based in New Zealand, principally research and development, manufacturing, marketing, sales and distribution and administration. The North America segment refers to all activities controlled by entities or employees based in the United States of America and Canada, principally sales, distribution and administration activities. The Europe segment includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, principally sales, distribution and administration activities. The Asia-Pacific segment refers to all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, principally sales, distribution and administration activities. The company was founded in 1934 and is headquartered in Auckland, New Zealand.

Historical Price Data

Date Open High Low Close Volume VWAP
17 Sep 2021 30.800 31.590 30.790 31.500 758,434 -
16 Sep 2021 30.360 30.620 30.140 30.540 525,512 -
15 Sep 2021 30.520 30.640 30.100 30.330 953,157 -
14 Sep 2021 31.110 31.120 30.240 30.340 764,305 -
13 Sep 2021 31.610 31.830 31.250 31.480 322,515 -
10 Sep 2021 31.770 31.870 31.350 31.620 344,825 -
09 Sep 2021 31.940 32.120 31.510 31.780 586,009 -
08 Sep 2021 32.530 32.790 31.630 31.700 688,954 -
07 Sep 2021 32.280 32.510 32.200 32.420 207,010 -
06 Sep 2021 31.970 32.520 31.740 32.510 521,785 -
03 Sep 2021 32.280 32.350 31.890 32.140 364,489 -
02 Sep 2021 31.540 32.190 31.150 32.190 421,461 -
01 Sep 2021 31.500 31.640 31.260 31.570 180,130 -
31 Aug 2021 31.860 32.140 31.750 31.790 391,862 -
30 Aug 2021 31.050 31.480 31.050 31.320 416,621 -
27 Aug 2021 30.800 31.175 30.560 30.870 597,861 -
26 Aug 2021 30.960 31.200 30.650 30.870 406,087 -
25 Aug 2021 32.090 32.090 31.010 31.070 440,655 -
24 Aug 2021 32.100 32.190 31.330 31.470 466,277 -
23 Aug 2021 32.130 32.480 31.840 32.100 304,390 -
20 Aug 2021 32.320 32.480 32.090 32.230 335,848 -
19 Aug 2021 31.820 32.260 31.660 32.260 598,976 -
Summary
Current 2 Weeks
(06 Sep 2021 to 17 Sep 2021)
31.970 32.790 30.100 31.500 5,672,506 -
Previous 2 Weeks
(23 Aug 2021 to 03 Sep 2021)
32.130 32.790 30.100 32.140 3,989,833 -
4 Weeks from
(26 Jul 2021 to 20 Aug 2021)
31.050 32.790 30.100 32.230 10,179,736 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.